Asano Y, Yamamoto N, Demura S, Hayashi K, et al. Combination therapy with immune checkpoint inhibitors and denosumab improves clinical outcomes in non-small cell lung cancer with bone metastases. Lung Cancer 2024;193:107858.
PMID: 38901176